NeuroStar Advanced Therapy Launches New ‘Tap Into a New Possibility’ Campaign for Depression Awareness

Neuronetics, Inc

MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced the launch of their new campaign to increase awareness of the impact of depression on millions of people. The campaign is called “Tap into a New Possibility” and illustrates how overwhelmed patients with major depressive disorder (MDD) feel about managing their condition, especially if they have not benefited from multiple treatment attempts. 

“Too many people are suffering, and traditional treatments don’t work for everyone. It’s critical that patients and their physicians are aware of all of the treatment options available to them, especially if they haven’t found the one that works for them yet,” stated Claire Sears, Vice President of Marketing at Neuronetics, Inc. “Our marketing spend this year demonstrates our commitment to investing in the category and making sure patients know about NeuroStar Advanced Therapy – a safe, effective, non-drug treatment for MDD.”

The omnichannel campaign launched on March 3rd and is being extended across owned channels and established health platforms, with a goal of reaching and educating more people who are seeking information about depression treatments and NeuroStar.

For more information about NeuroStar, please visit

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.

Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.